Chi Hye Park
- Molecular Medicine top 0.1%
- Endocrinology top 0.5%
- Pollution top 1%
- Pharmacology top 1%
- Food Science top 2%
- Co-authors
- David C. HooperGeorge A. JacobyAri RobicsekDaniel F. SahmJacob StrahilevitzKaren BushDarren AbbanatMark J. Macielag
- Topics
- Antibiotic Resistance in Bacteria (7 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)Escherichia coli research studies (2 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Chi Hye Park
9 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Molecular Medicine 1.9k
- Endocrinology 832
- Pollution 679
- Pharmacology 603
- Food Science 446
Countries citing papers authored by Chi Hye Park
This map shows the geographic impact of Chi Hye Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Hye Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Hye Park more than expected).
Fields of papers citing papers by Chi Hye Park
This network shows the impact of papers produced by Chi Hye Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Hye Park. The network helps show where Chi Hye Park may publish in the future.
Co-authorship network of co-authors of Chi Hye Park
This figure shows the co-authorship network connecting the top 25 collaborators of Chi Hye Park. A scholar is included among the top collaborators of Chi Hye Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Hye Park. Chi Hye Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 24 | |
| 3 | 65 | |
| 4 | 218 | |
| 5 | 284 | |
| 6 | 105 | |
| 7 | Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzymebreakdown → | 631 |
| 8 | 193 | |
| 9 | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferasebreakdown → | 750 |
About Chi Hye Park
Chi Hye Park is a scholar working on Molecular Medicine, Endocrinology and Pharmacology, having authored 9 papers that have together received 2.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Escherichia coli research studies (2 papers). The work is most often cited by research in Molecular Medicine (1.9k citations), Endocrinology (832 citations) and Pollution (679 citations). Chi Hye Park has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include David C. Hooper, George A. Jacoby, Ari Robicsek, Daniel F. Sahm, Jacob Strahilevitz, Karen Bush, Darren Abbanat, Mark J. Macielag, Hong Bin Kim and Eui-Chong Kim. Their work appears in journals such as Nature Medicine, Biochemistry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.